+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Increasing anticholinergic burden and delirium in palliative care inpatients



Increasing anticholinergic burden and delirium in palliative care inpatients



Palliative Medicine 28(4): 335-341



Delirium may complicate the hospital course and adversely impact remaining quality of life for palliative care inpatients. Medications with anticholinergic properties have been linked to delirium within elderly populations via serum anticholinergic assays. The aim of this study is to determine whether increasing anticholinergic burden, as measured using a clinical assessment tool, is associated with an increase in delirium among palliative care inpatients. This study was completed as a retrospective, case-control study. Veterans admitted to the Veterans Affairs Boston Healthcare System and consulted to the palliative care service were considered for inclusion. Increase in anticholinergic burden from admission through hospital day 14 was assessed using the Anticholinergic Risk Scale. Presence of delirium was determined by use of a validated chart review instrument. A total of 217 patients were analyzed, with a mean age of 72.9 (±12.8) years. The overall delirium rate was 31% (n = 67). Patients with an increase in Anticholinergic Risk Scale (n = 72 (33%)) were 40% more likely to experience delirium (odds ratio = 1.44, 95% confidence interval = 1.07-1.94) compared to those without increase (n = 145 (67%)). After adjustment for age, brain metastasis, intensive care unit admission, illness severity, opiate use, and admission Anticholinergic Risk Scale using multivariable modeling, delirium risk remained significantly higher in patients with an Anticholinergic Risk Scale increase compared to those without increase (adjusted odds ratio = 1.43, 95% confidence interval = 1.04-1.94). An increase in Anticholinergic Risk Scale from admission was associated with delirium in palliative care inpatients. While additional study is needed, anticholinergic burden should be increased cautiously in palliative inpatients, and those with increases should be closely followed for delirium.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053807799

Download citation: RISBibTeXText

PMID: 24534725

DOI: 10.1177/0269216314522105


Related references

Anticholinergic burden in older inpatients on psychotropic medication: do we care?. Australasian Psychiatry 25(6): 566-570, 2017

The recognition and documentation of delirium in hospital palliative care inpatients. Palliative and Supportive Care 8(2): 133-136, 2010

Anticholinergic delirium: Assessing the role of anticholinergic burden in the elderly. Current Psychosis and Therapeutics Reports 2(1): 33-36, 2004

Symptoms of depression and delirium assessed serially in palliative-care inpatients. Psychosomatics 50(5): 506-514, 2010

Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients. Gynecologic Oncology 136(3): 424-428, 2015

Improvement in Symptom Burden Within One Day After Palliative Care Consultation in a Cohort of Gynecologic Oncology Inpatients (FR435-B). Journal of Pain and Symptom Management 49(2): 366-367, 2015

Delirium diagnostic and classification challenges in palliative care: subsyndromal delirium, comorbid delirium-dementia, and psychomotor subtypes. Journal of Pain and Symptom Management 48(2): 199-214, 2015

Anticholinergic burden in Parkinson's disease inpatients. European Journal of Clinical Pharmacology 71(10): 1271-1277, 2016

Anticholinergic burden in older psychiatric inpatients. Australasian Psychiatry 26(4): 438-439, 2018

Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Archives of Internal Medicine 161(8): 1099-1105, April 23, 2001

In geriatric patients, delirium symptoms are related to the anticholinergic burden. Geriatrics and Gerontology International 16(4): 424-431, 2017

Anticholinergic burden and delirium in elderly patients during acute hospital admission. Revista Espanola de Geriatria Y Gerontologia 51(4): 217-220, 2017

A comparison of the revised Delirium Rating Scale (DRS-R98) and the Memorial Delirium Assessment Scale (MDAS) in a palliative care cohort with DSM-IV delirium. Palliative and Supportive Care 13(4): 937-944, 2016

Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs and Aging 30(2): 103-112, 2013

Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. International Psychogeriatrics 14(3): 307-310, 2002